Literature DB >> 31501632

Eruptive palmoplantar lesions induced by capecitabine: report of a case evaluated with dermoscopy.

José A García-Lozano1, Jorge Ocampo-Candiani1, Roger A González-Ramírez1,2,3.   

Abstract

Capecitabine is a prodrug used primarily as a chemotherapeutic agent. Despite its good tolerance, it has several adverse effects, including the appearance of eruptive nevi. We present the case of a patient, with a history of EC IV breast adenocarcinoma and superficial extension melanoma, which developed 2 weeks after the start of therapy with capecitabine multiple eruptive palmoplantar pigmented lesions, with diverse benign dermatoscopic patterns. With the increasing incidence of solid tumors, these agents are being more used. It is important that the treating physician knows its adverse effects and apply non-invasive diagnostic tools like dermoscopy to avoid unnecessary biopsies. Copyright:
© 2019 Permanyer.

Entities:  

Keywords:  Biopsia; Biopsy; Capecitabina; Capecitabine; Dermatoscopia; Dermoscopy; Lesiones pigmentadas; Nevogenesis; Nevogénesis; Pigmented lesions

Mesh:

Substances:

Year:  2019        PMID: 31501632     DOI: 10.24875/CIRU.19000689

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  1 in total

1.  Beware the Unexpected Infection: Disseminated Varicella Zoster Virus Mimicking A Drug Eruption.

Authors:  Dina Adimora-Onwuka; Mary Ann Kirkconnell Hall
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.